Galmed Pharmaceuticals Ltd (GLMD)



Galmed Pharmaceutical Ltd. is a biopharmaceutical company. The Company focuses on the development and commercialization of treatment of liver diseases and cholesterol gallstones. Galmed Pharmaceutical offers its products to the healthcare and medical industries.

Data as of 2021-01-16
Market Cap75.796 Million Shares Outstanding21.113 Million Avg 30-day Volume146.083 Thousand
P/E Ratio Dividend Yield EPS-0.76
Price/Sales Price cash flow ratio Price free cash flow ratio-10.0
Book Value3.67 Price to Tangible Book1.4 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.2441
BETA2.31211 52-week High/Low6.683 / 2.96 Stddev0.205924
View SEC Filings from GLMD instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 26 25 4.0% 11 (0.72%) 11 (0.71%) 0.0%
13F shares: 6.732 Million 7.419 Million -9.27% 5.907 Million 6.433 Million -8.17%
% Ownership 31.8832 35.1402 -9.27% 27.9798 30.4697 -8.17%
New Positions: 5 2 150.0% 2
Increased Positions 6 8 -25.0% 2 4 -50.0%
Closed Positions 3 8 -62.5% 2 4 -50.0%
Reduced Positions 4 3 33.33% 3 2 50.0%
Total Calls 500 700 -28.57%
Total Puts 0 0
PUT/CALL Ratio 0.0 0.0
1 hedge funds and active managers as identified by through public filings.

Funds Holding GLMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GLMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)


Open Market Sells (S)


Exercise Derivative Conversion (M)


Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments